{"version":"1.0","type":"link","title":"Setipiprant - Newikis","description":"Setipiprant (INN; developmental code names ACT-129968, KYTH-105) is an investigational drug developed for the treatment of asthma and scalp hair loss. It was originally developed by Actelion and acts as a selective, orally available antagonist of the prostaglandin D2 receptor 2 (DP2). The drug is…","provider_name":"Newikis","provider_url":"https://newikis.com","cache_age":86400,"thumbnail_url":"https://thumb.wikimedia.org/wikipedia/commons/thumb/a/a3/Setipiprant.svg/1280px-Setipiprant.svg.png","thumbnail_width":1280,"thumbnail_height":1108}